You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
內地第五批國家藥品帶量採購目錄被流出 據報有60個品種入圍
阿思達克 04-16 07:56
據內地媒體報道,業內流出一份由國家組織藥品聯合採購辦公室印發的《關於報送第五批國家組織藥品集中採購品種範圍相關採購數據的通知》。該通知公布帶量採購藥品名單顯示,第五輪帶量採購一共涉及60個品種,207個品規。相比此前第四批帶量採購的45個品種,此輪帶量採購所涉藥品範圍進一步擴大,品種和品規數均為歷次之最。

該通知要求,於4月18日24:00前,各省可通過系統進行報量操作測試,4月19日正式啟動報量,各省選擇醫療機構直報或省級代報方式,填報相關藥品預採購量,並於4月30日24:00前完成。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account